The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma

被引：30

作者：

Chowdhury, F. U. ^{[1
,2
]}

Bradley, K. M. ^{[1
,2
]}

Gleeson, F. V. ^{[1
,2
]}

机构：

[1] Oxford Radcliffe Hospitals, Dept Nucl Med, Oxford OX3 9DU, England

[2] Oxford Radcliffe Hospitals, Dept Radiol, Oxford OX3 9DU, England

来源：

CLINICAL RADIOLOGY | 2008年 / 63卷 / 12期

关键词：

D O I：

10.1016/j.crad.2008.05.010

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG) is now established in the management of oncology patients. With increasing availability and a constantly advancing body of evidence, the role of FDG PET/CT in oesophageal cancer is set to expand to include initial staging, assessment of disease response, therapy planning, and detection of disease recurrence. This article reviews the utility of FDG PET/CT in the management of oesophageal carcinoma, discussing its role and limitations in the imaging of these patients. (C) 2008 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：1297 / 1309

页数：13

共 114 条

[1] Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: Histopathologic comparison [J].

Agress, H ;

Cooper, BZ .

RADIOLOGY, 2004, 230 (02) :417-422

[2] PRINCIPLES OF SURGICAL-TREATMENT FOR CARCINOMA OF THE ESOPHAGUS - ANALYSIS OF LYMPH-NODE INVOLVEMENT [J].

AKIYAMA, H ;

TSURUMARU, M ;

KAWAMURA, T ;

ONO, Y .

ANNALS OF SURGERY, 1981, 194 (04) :438-446

[3]

*AM JOINT COMM CAN, 2002, AM JOINT COMM CANC C, P301

[4]

ANDERSON LL, 1982, CANCER, V50, P1587, DOI 10.1002/1097-0142(19821015)50:8<1587::AID-CNCR2820500820>3.0.CO

[5]

2-S

[6] Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET [J].

Antoch, G ;

Saoudi, N ;

Kuehl, H ;

Dahmen, G ;

Mueller, SP ;

Beyer, T ;

Bockisch, A ;

Debatin, JF ;

Freudenberg, LS .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) :4357-4368

[7]

Antoch G, 2004, J NUCL MED, V45, p56S

[8]

Bancewicz J, 2002, LANCET, V359, P1727

[9]

Bar-Shalom R, 2003, J NUCL MED, V44, P1200

[10] The additional value of PET/CT over PET in FDG imaging of oesophageal cancer [J].

Bar-Shalom, R ;

Guralnik, L ;

Tsalic, M ;

Leiderman, M ;

Frenkel, A ;

Gaitini, D ;

Ben-Nun, A ;

Keidar, Z ;

Israel, O .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (08) :918-924

← 1 2 3 4 5 6 7 8 9 10 →